M&ACan Sanofi buy its way into in vivo CAR-T?Recent preclinical data published in Molecular Therapy suggest the company may be closer than ever to answering that question. Its platform did not emerge from a single discovery programme, but from … more ➔
WhiteLab GenomicsInterviewAI: Breaking barriers in CNS researchDelivering therapeutic genetic material safely to the correct target in the body is one of the big challenges of modern medicine. We talked to David Del Bourgo, CEO of WhiteLab Genomics, about how AI … more ➔
Sevan Habeshian & Christian Heinis et al. https://www.nature.com/articles/s41467-022-31428-Drug DesignMacrocycles: big is the new beautifulIn the evolving landscape of drug discovery and new design, scientists and pharmaceutical innovators continually strive to develop therapies that are both highly selective and clinically effective, … more ➔
ServierVenture CapitalInside Servier’s new €200M venture fundWith the launch of Servier Ventures announced in January and a €200 million commitment to biotech investment, Servier is stepping up its engagement in early-stage innovation in oncology and neurology. … more ➔
CONCEPT HEIDELBERG GmbHPharmaCongressProfessor Wallhäußer Innovation Award 2026The 2026 Professor Wallhäußer Innovation Award was presented during this year’s PharmaCongress & PharmaTechnica 2026 at the end of March. First place went to AstraZeneca for the project “Automated … more ➔
Svitlana Hulko-freepik.comDeep DiveCan biotech finally fix infertility?According to the WHO, one adult in six globally is affected by infertility, but beyond this statistic, infertility is best understood as a couple’s problem, even when the underlying biology … more ➔
www.istockphoto.com/YuriVenture StudiosEurope’s distinct biotech venture studio modelFor decades, biotech companies were formed around a discovery: a promising biological signal, a novel target, a platform emerging from academic research. Now a different formation model is gaining momentum: … more ➔
SLASEventSLAS Announces the Cohort for Innovation AveNEW at SLAS Europe 2026Twelve emerging life science startups to showcase enabling technologies at the SLAS European Conference and Exhibition in Vienna, 19-21 May 2026 more ➔
VanessaSpencer - stock.adobe.comBiotech ClusterPortugal’s biotech industry is growing upFor years, Portugal sat just outside Europe’s main biotech conversation: scientifically credible, strong in research, but too small, too fragmented and too thinly financed to compete with the established … more ➔
Kelli McClintock auf UnsplashStartups10 European Startups to watch in 2026Ten young European biotechs are heading into 2026 with the kind of momentum that can quickly turn promising science into defining data: first clinical entries, platform-to-pipeline transitions, and funding … more ➔
WhiteLab Genomics
Sevan Habeshian & Christian Heinis et al. https://www.nature.com/articles/s41467-022-31428-
Servier
CONCEPT HEIDELBERG GmbH
Svitlana Hulko-freepik.com
www.istockphoto.com/Yuri
SLAS
VanessaSpencer - stock.adobe.com
Kelli McClintock auf Unsplash